Pain News and Research

Latest Pain News and Research

Roundup: Texas probes Xerox in Medicaid overbilling; Miss. abortion clinic fights to stay open

Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.

5 Sep 2012

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that it has initiated the first of two Phase 2a clinical studies with Z160, its first-in-class, oral, state-dependent, selective N-type calcium channel blocker for the treatment of chronic neuropathic pain indications.

5 Sep 2012

FDA approves Bosulif to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.

5 Sep 2012

Young doctors seek to alter practice of medicine; Medical schools push training in addiction

The Associated Press examines how tech-savy young doctors are changing medicine, and KHN looks at efforts to train doctors to recognize how addictions complicate other health problems.

5 Sep 2012

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.

4 Sep 2012

First Edition: September 4, 2012

Today's early morning highlights from the major news organizations, including previews of the Democratic convention and a New York Times analysis of how the Obama and Romney campaigns vary on Medicaid policy.

4 Sep 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

4 Sep 2012

Data from ESTEVE’s S1RA E-52862 Phase I trial programme on pain

ESTEVE announces the recent publication of data from the Phase I clinical trial programme of a novel, highly potent and selective, once-daily, S1RA E-52862, developed by the ESTEVE R&D team, in the British Journal of Clinical Pharmacology.

4 Sep 2012

MRI lesions match site of recent-onset inflammatory back pain

Patients with recent inflammatory back pain who undergo examination with magnetic resonance imaging typically show inflammation at the site of their pain, a study confirms.

3 Sep 2012

Novel scoring system shows sclerotherapy improves pain of venous malformation

Ethanol sclerotherapy reduces the signs and symptoms of venous malformation in the majority of patients after approximately two sessions, report Japanese researchers who used a novel scoring system to evaluate treatment outcomes.

3 Sep 2012

Potassium-channel autoimmunity linked to chronic pain

A substantial proportion of patients with voltage-gated potassium channel-complex autoimmunity experience chronic idiopathic pain, although the specific antigenic complex associated with pain remains to be determined, conclude US scientists.

3 Sep 2012

Scientists succeed in clarifying molecular signature of hantaviruses

Scientists at Charité - Universitätsmedizin Berlin and Labor Berlin GmbH have succeeded in clarifying the molecular signature of the viruses that lead to an increasing size and number of hantavirus outbreaks in Germany.

3 Sep 2012

MDA7 compound shows promise against Alzheimer's disease

A compound developed to treat neuropathic pain has shown potential as an innovative treatment for Alzheimer's disease, according to a study by researchers at Cleveland Clinic's Lerner Research Institute and Anesthesiology Institute.

3 Sep 2012

Unique approaches to improve pain management in hospitals and clinical practices

Five recent Johns Hopkins University School of Nursing DNP graduates have taken different and unique approaches in working to improve the implementation of pain management in hospitals and clinical practices.

1 Sep 2012

Targeted intervention improves safety of MRI scans for children with sickle cell disease

Jude Children's Research Hospital reports success using a targeted educational approach to teach young patients to remain motionless during MRI scans, making the process safer.

1 Sep 2012

Some smaller clots may not require potentially risky treatment

Men and women who undergo joint replacement procedures, as well as those who have significant fractures, tend to be at an increased risk of developing pulmonary emboli (PE), blood clots that travel to the lungs where they may cause serious complications and even death.

1 Sep 2012

Astellas Pharma receives FDA approval for Xtandi to treat metastatic CRPC

The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.

1 Sep 2012

MRI detects high prevalence of abnormalities associated with knee osteoarthritis

A study conducted by researchers at Boston University School of Medicine (BUSM) shows that magnetic resonance imaging (MRI) detected a high prevalence of abnormalities associated with knee osteoarthritis in middle-aged and elderly patients that had no evidence of knee osteoarthritis in X-ray images.

1 Sep 2012

French data highlight women under 60 at risk for heart disease

An analysis of four French registries has shown a dramatic drop in ST-segment-elevation myocardial infarction mortality from 1995 to 2010, accompanied by a significant change in patient characteristics.

31 Aug 2012

Non-pain-related factors predict long-term opioid use after surgery

Non-pain-related factors—including previous use of pain medications, high perceived risk of addiction, and symptoms of depression—increase the risk of continuing to use strong pain-relieving drugs several months after surgery, reports a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

31 Aug 2012

Pain News and Research

Latest Pain News and Research

Roundup: Texas probes Xerox in Medicaid overbilling; Miss. abortion clinic fights to stay open

Zalicus commences first of two Z160 Phase 2a clinical studies for chronic neuropathic pain

FDA approves Bosulif to treat chronic myelogenous leukemia

Young doctors seek to alter practice of medicine; Medical schools push training in addiction

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

First Edition: September 4, 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Data from ESTEVE’s S1RA E-52862 Phase I trial programme on pain

MRI lesions match site of recent-onset inflammatory back pain

Novel scoring system shows sclerotherapy improves pain of venous malformation

Potassium-channel autoimmunity linked to chronic pain

Scientists succeed in clarifying molecular signature of hantaviruses

MDA7 compound shows promise against Alzheimer's disease

Unique approaches to improve pain management in hospitals and clinical practices

Targeted intervention improves safety of MRI scans for children with sickle cell disease

Some smaller clots may not require potentially risky treatment

Astellas Pharma receives FDA approval for Xtandi to treat metastatic CRPC

MRI detects high prevalence of abnormalities associated with knee osteoarthritis

French data highlight women under 60 at risk for heart disease

Non-pain-related factors predict long-term opioid use after surgery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Pain News and Research

Latest Pain News and Research

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in